Related news from |
Wed, 06 Nov 2024 14:40:13 +0000 |
Here's Why Cencora (COR) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
|
Wed, 06 Nov 2024 11:35:00 +0000 |
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
CONSHOHOCKEN, Pa., November 06, 2024--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent to $79.1 billion. Revenue increased 12.1 percent to $294.0 billion for the fiscal year. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $0.02 for the September quarter of fiscal 2024, compared to $1.72 in the prior year quarter. Adjusted diluted EPS, which is a
|
Wed, 06 Nov 2024 11:30:00 +0000 |
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
CONSHOHOCKEN, Pa., November 06, 2024--Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America ("RCA"), a leading management services organization (MSO) of retina specialists, from Webster Equity Partners.
|
Mon, 04 Nov 2024 13:30:00 +0000 |
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
CONSHOHOCKEN, Pa., November 04, 2024--Cencora, Inc. (NYSE: COR) today announced the appointment of Francois Mandeville as Executive Vice President, Strategy and M&A, and Pawan Verma as Executive Vice President, Chief Data and Information Officer. Both leaders will join Cencora’s enterprise leadership team, bringing their extensive experience and expertise to help advance the company’s pharmaceutical-centric strategy and drive growth for Cencora and its customers.
|
Sat, 26 Oct 2024 12:00:24 +0000 |
We Think Cencora (NYSE:COR) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
|
Mon, 21 Oct 2024 13:40:12 +0000 |
Why Cencora (COR) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
|
Fri, 18 Oct 2024 11:00:32 +0000 |
Possible Bearish Signals With Cencora Insiders Disposing Stock
In the last year, many Cencora, Inc. ( NYSE:COR ) insiders sold a substantial stake in the company which may have...
|
Tue, 15 Oct 2024 16:10:17 +0000 |
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
|
Fri, 11 Oct 2024 13:45:08 +0000 |
Here's Why Cencora (COR) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
|
Thu, 10 Oct 2024 13:00:20 +0000 |
If EPS Growth Is Important To You, Cencora (NYSE:COR) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
|
Fri, 04 Oct 2024 13:00:27 +0000 |
Those who invested in Cencora (NYSE:COR) five years ago are up 193%
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...
|
Tue, 01 Oct 2024 11:30:00 +0000 |
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
CONSHOHOCKEN, Pa., October 01, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2024 on Wednesday, November 6, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 6, 2024.
|
Fri, 27 Sep 2024 11:00:00 +0000 |
Why Drug Distributors Are Buying Cancer Specialists
Most Americans pick up their prescription drugs at the local pharmacy, but many pricey medications are bought directly by medical providers. Think, for example, of a chemotherapy infusion delivered at a doctor’s office. Now, the big three U.S. drug wholesalers— McKesson Cencora and Cardinal Health —are taking control of the doctors, too, to lock them in as customers.
|
Fri, 20 Sep 2024 11:00:30 +0000 |
These 4 Measures Indicate That Cencora (NYSE:COR) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
|
Sat, 14 Sep 2024 13:00:19 +0000 |
Cencora Insiders Sell US$13m Of Stock, Possibly Signalling Caution
The fact that multiple Cencora, Inc. ( NYSE:COR ) insiders offloaded a considerable amount of shares over the past year...
|
Tue, 10 Sep 2024 11:01:06 +0000 |
Here's Why We Think Cencora (NYSE:COR) Might Deserve Your Attention Today
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
|
Fri, 30 Aug 2024 12:00:24 +0000 |
Investing in Cencora (NYSE:COR) five years ago would have delivered you a 195% gain
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
|
Thu, 22 Aug 2024 13:45:09 +0000 |
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
|
Thu, 15 Aug 2024 11:30:00 +0000 |
Cencora Elects Frank Clyburn to Its Board of Directors
CONSHOHOCKEN, Pa., August 15, 2024--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Frank Clyburn as a new independent director, effective October 1, 2024. With the election of Mr. Clyburn, the Board of Directors will increase to thirteen members.
|
Sun, 11 Aug 2024 11:00:20 +0000 |
Insiders At Cencora Sold US$13m In Stock, Alluding To Potential Weakness
The fact that multiple Cencora, Inc. ( NYSE:COR ) insiders offloaded a considerable amount of shares over the past year...
|